Page 485 - Read Online

Maner et al. J Cancer Metastasis Treat 2020;6:37 I http://dx.doi.org/10.20517/2394-4722.2020.60 Page 37 of 40

117. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
118. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, et al. IL-23 promotes tumour incidence and growth. Nature 2006;442:461-5.
119. Tchernev G, Guarneri C, Bevelacqua V, Wollina U. Carcinoma cuniculatum in course of etanercept: blocking autoimmunity but
propagation of carcinogenesis? Int J Immunopathol Pharmacol 2014;27:261-6.
120. Chen Y, Sun J, Yang Y, Huang Y, Liu G. Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews
and meta-analyses. Clin Rheumatol 2016;35:1-18.
121. Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol 2009;60:137-43.
122. Basosquamous Cell Cancer. In: Hoffman H, editor. Iowa Head and Neck Protocols: University of Iowa Health Care; 2017.
123. Akay BN, Saral S, Heper AO, Erdem C, Rosendahl C. Basosquamous carcinoma: Dermoscopic clues to diagnosis. J Dermatol
2017;44:127-34.
124. Anand RL, Collins D, Chapman A. Basosquamous carcinoma: appearance and reality. Oxf Med Case Rep 2017;2017.
125. Tarapore E, Atwood SX. Defining the genetics of basosquamous carcinoma. J Invest Dermatol 2019;139:2258-60.
126. Murthaiah P, Truskinovsky A, Shah S, Dudek A. Collision tumor versus multiphenotypic differentiation: a case of carcinoma with features
of colonic and lung primary tumors. Anticancer Res 2009;29:1495-7.
127. Lara F, Santamaría JR, Garbers LM. Recurrence rate of basal cell carcinoma with positive histopathological margins and related risk
factors. An Bras Dermatol 2017;92:58-62.
128. Oldbury J, Wain R, Abas S, Dobson C, Iyer S. Basosquamous carcinoma: a single centre clinicopathological evaluation and proposal of
an evidence-based protocol. J Skin Cancer 2018;2018.
129. Piva de Freitas P, Senna CG, Tabai M, Chone CT, Altemani A. Metastatic basal cell carcinoma: a rare manifestation of a common disease.
Case Rep Med 2017;2017.
130. Major A, Anderson M. Not just skin deep: distant metastases from cutaneous squamous cell carcinoma. Am J Med 2017;130.
131. Alam M. Basal cell carcinoma recurrence after mohs surgery. U.S. National Laboratory of Medicine; 2012.
132. Metastatic Squamous Cell Carcinoma. Transplant Skin Cancer Network: University of California San Francisco. Available from: https://
skincancer.ucsf.edu/metastatic-squamous-cell-carcinoma. [Last accessed on 7 Sep 2020]
133. van Lee CB, Roorda BM, Wakkee M, Voorham Q, Mooyaart AL, et al. Recurrence rates of cutaneous squamous cell carcinoma of the
head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study. Br J Dermatol 2019;181:338-43.
134. Martin RC 2nd, Edwards MJ, Cawte TG, Sewell CL, McMasters KM. Basosquamous carcinoma: analysis of prognostic factors
influencing recurrence. Cancer 2000;88:1365-9.
135. Chiang A, Tan CZ, Kuonen F, Hodgkinson LM, Chiang F, et al. Genetic mutations underlying phenotypic plasticity in basosquamous
carcinoma. J Invest Dermatol 2019;139:2263-71.e5.
136. Zhao X, Ponomaryov T, Ornell KJ, Zhou P, Dabral SK, et al. RAS/MAPK activation drives resistance to smo inhibition, metastasis, and
tumor evolution in shh pathway-dependent tumors. Cancer Res 2015;75:3623-35.
137. Osawa H, Ohnishi H, Takano K, Noguti T, Mashima H, et al. Sonic hedgehog stimulates the proliferation of rat gastric mucosal cells
through ERK activation by elevating intracellular calcium concentration. BiochemBiophys Res Commun 2006;344:680-7.
138. Solomon JA, Iarrobino A, Shutty B. Calcium dependence of the SHH pathway and theoretical implications in oral treatment of locally
advanced or metastatic basal cell carcinomas. Cutaneous Oncol Today 2011:9-13.
139. Ji J, Wernli M, Mielgo A, Buechner SA, Erb P. Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNA. Gene
Therapy 2005;12:678-84.
140. Hardwick JM, Soane L. Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol 2013;5.
141. N Sivrikoz O, Kandiloğlu G. The effects of cyclin D1 and Bcl-2 expressıon on aggressive behavior in basal cell and basosquamous
carcinoma. Iran J Pathol 2015;10:185-91.
142. Rishikaysh P, Dev K, Diaz D, Qureshi WMS, Filip S, et al. Signaling involved in hair follicle morphogenesis and development. Int J Mol
Sci 2014;15:1648-70.
143. Ellis T, Smyth I, Riley E, Bowles J, Adolphe C, et al. Overexpression of sonic hedgehog suppresses embryonic hair follicle
morphogenesis. Dev Biol 2003;263:203-15.
144. Kasper M, Jaks V, Are A, Bergström Å, Schwäger A, et al. Wounding enhances epidermal tumorigenesis by recruiting hair follicle
keratinocytes. Proc Nat Acad Sci 2011;108:4099-104.
145. Peterson SC, Eberl M, Vagnozzi AN, Belkadi A, Veniaminova NA, et al. Basal cell carcinoma preferentially arises from stem cells within
hair follicle and mechanosensory niches. Cell Stem Cell 2015;16:400-12.
146. Gutzmer R, Solomon J. Hedgehog pathway inhibition for the treatment of basal cell carcinoma. Target Oncol 2019;14:253-67.
147. Duman N, Şen Korkmaz N, Erol Z. Host immune responses and peritumoral stromal reactions in different basal cell carcinoma subtypes:
histopathological comparison of basosquamous carcinoma and high-risk and low-risk basal cell carcinoma subtypes. Turk J Med Sci
2016;46:28-34.
148. Zainab H, Sultana A, Shaimaa. Stromal desmoplasia as a possible prognostic indicator in different grades of oral squamous cell
carcinoma. J Oral Maxillofac Pathol 2019;23:338-43.
149. Kaporis H, Guttman-Yassky E, Lowes M, Haider A, Fuentes-Dunclan J, et al. Human basal cell carcinoma is associated with Foxp3+ T
cells in a Th2 dominant microenvironment. J Invest Dermatol 2007;127:2391-8.
150. Siegel RL, Miller KD, Jemal A. Cancer Statistics. CA Cancer J Clin 2017;67:7-30.
151. Skin Cancer Facts & Statistics. 2020. Available from: https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/. [Last
accessed on 7 Sep 2020]